Australia's largest stock trading and investment forum Australia's #1 stock forum

AB1 abarta resources limited

0.00%

18.0¢

Nah. Charting analysis is most valid for highly liquid stocks...

First 694 Last

Share
Profile

Follow
hercules007

4,535 Posts.

111

02/09/22

14:07

Post #: 63486475
Share

Originally posted by Massyestreen: ↑

Unfortunately at the moment in my humble an non expert opinion the charts are bearish.
Most of the downward price action has occurred under higher volume meaning the bears are in control.
For the last month where we have seen the price fluctuate and generally have an increasing price action, the volume has been low.
If we can break the $3 mark with high volume then we will see a chart turnaround.
On the flip side if we see a drop below $2 then the trend that started in Feb this year continues.
Until one of those things happen we are just sitting in no mans land trending sideways.

Having said that I am bullish on the company for what the company is doing, not what the chart looks like, but the chart stuff is a fun pass time while we wait for some price action

DYOR
Mass (not an expert)

Expand

Nah.
Charting analysis is most valid for highly liquid stocks with easy/free participation of the public. It's not the case for Animoca on Primary Markets where sellers are many including retail penny stock speculators but buyers are few and far between.

AB1 Price at posting: 18.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 694 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Nah. Charting analysis is most valid for highly liquid stocks...

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News